These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
425 related items for PubMed ID: 9165015
1. Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats. Vanderschueren D, van Herck E, Nijs J, Ederveen AG, De Coster R, Bouillon R. Endocrinology; 1997 Jun; 138(6):2301-7. PubMed ID: 9165015 [Abstract] [Full Text] [Related]
2. Aromatization of androgens is important for skeletal maintenance of aged male rats. Vanderschueren D, Van Herck E, De Coster R, Bouillon R. Calcif Tissue Int; 1996 Sep; 59(3):179-83. PubMed ID: 8694895 [Abstract] [Full Text] [Related]
3. Skeletal effects of estrogen deficiency as induced by an aromatase inhibitor in an aged male rat model. Vanderschueren D, Boonen S, Ederveen AG, de Coster R, Van Herck E, Moermans K, Vandenput L, Verstuyf A, Bouillon R. Bone; 2000 Nov; 27(5):611-7. PubMed ID: 11062346 [Abstract] [Full Text] [Related]
4. Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency. Vanderschueren D, Van Herck E, Suiker AM, Visser WJ, Schot LP, Bouillon R. Endocrinology; 1992 May; 130(5):2906-16. PubMed ID: 1572302 [Abstract] [Full Text] [Related]
5. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys. Wickman S, Kajantie E, Dunkel L. J Clin Endocrinol Metab; 2003 Aug; 88(8):3785-93. PubMed ID: 12915670 [Abstract] [Full Text] [Related]
6. The aged male rat as a model for human osteoporosis: evaluation by nondestructive measurements and biomechanical testing. Vanderschueren D, Van Herck E, Schot P, Rush E, Einhorn T, Geusens P, Bouillon R. Calcif Tissue Int; 1993 Nov; 53(5):342-7. PubMed ID: 8287323 [Abstract] [Full Text] [Related]
7. The estrogen receptor ligand ICI 182,780 does not impair the bone-sparing effects of testosterone in the young orchidectomized rat model. Vandenput L, Swinnen JV, Van Herck E, Verstuyf A, Boonen S, Bouillon R, Vanderschueren D. Calcif Tissue Int; 2002 Mar; 70(3):170-5. PubMed ID: 11907714 [Abstract] [Full Text] [Related]
8. Androgen resistance and deficiency have different effects on the growing skeleton of the rat. Vanderschueren D, Van Herck E, Geusens P, Suiker A, Visser W, Chung K, Bouillon R. Calcif Tissue Int; 1994 Sep; 55(3):198-203. PubMed ID: 7987733 [Abstract] [Full Text] [Related]
9. Effects of tower climbing exercise on bone mass, strength, and turnover in orchidectomized growing rats. Notomi T, Okazaki Y, Okimoto N, Tanaka Y, Nakamura T, Suzuki M. J Appl Physiol (1985); 2002 Sep; 93(3):1152-8. PubMed ID: 12183513 [Abstract] [Full Text] [Related]
10. Comparative effects of bicalutamide (Casodex) versus orchidectomy on bone mineral density, bone remodelling, and bone biomechanics in healthy rats. Lefort M, Díaz Curiel M, Carrascal MT, Méndez-Dávila C, de la Piedra C. Urol Int; 2005 Sep; 74(4):301-7. PubMed ID: 15897693 [Abstract] [Full Text] [Related]
11. Lasofoxifene (CP-336,156), a selective estrogen receptor modulator, prevents bone loss induced by aging and orchidectomy in the adult rat. Ke HZ, Qi H, Crawford DT, Chidsey-Frink KL, Simmons HA, Thompson DD. Endocrinology; 2000 Apr; 141(4):1338-44. PubMed ID: 10746637 [Abstract] [Full Text] [Related]
12. Orchidectomy-induced alterations in volumetric bone density, cortical porosity and strength of femur are attenuated by dietary conjugated linoleic acid in aged guinea pigs. DeGuire JR, Mak IL, Lavery P, Agellon S, Wykes LJ, Weiler HA. Bone; 2015 Apr; 73():42-50. PubMed ID: 25524178 [Abstract] [Full Text] [Related]
13. Alfacalcidol prevents aromatase inhibitor (Letrozole)-induced bone mineral loss in young growing female rats. Mohamed I, Yeh JK. J Endocrinol; 2009 Aug; 202(2):317-25. PubMed ID: 19420010 [Abstract] [Full Text] [Related]
14. Treatment with growth hormone and IGF-I in growing rats increases bone mineral content but not bone mineral density. Rosen HN, Chen V, Cittadini A, Greenspan SL, Douglas PS, Moses AC, Beamer WG. J Bone Miner Res; 1995 Sep; 10(9):1352-8. PubMed ID: 7502707 [Abstract] [Full Text] [Related]
15. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats. Ke HZ, Simmons HA, Pirie CM, Crawford DT, Thompson DD. Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465 [Abstract] [Full Text] [Related]
16. Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model. Venken K, De Gendt K, Boonen S, Ophoff J, Bouillon R, Swinnen JV, Verhoeven G, Vanderschueren D. J Bone Miner Res; 2006 Apr; 21(4):576-85. PubMed ID: 16598378 [Abstract] [Full Text] [Related]
17. Early induction of alterations in cancellous and cortical bone histology after orchiectomy in mature rats. Gunness M, Orwoll E. J Bone Miner Res; 1995 Nov; 10(11):1735-44. PubMed ID: 8592951 [Abstract] [Full Text] [Related]
19. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment. Kimoto A, Tanaka M, Nozaki K, Mori M, Fukushima S, Mori H, Shiroya T, Nakamura T. Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179 [Abstract] [Full Text] [Related]